-
Enrollment for Medivation Study - Analyst Blog
Friday, December 3, 2010 - 4:06am | 637Medivation, Inc. (MDVN) and partner Astellas Pharma Inc. recently announced that they have finished enrolling patients for a phase III study of their prostate cancer candidate, MDV3100. The phase III study, AFFIRM, is being conducted in men with castration-resistant prostate cancer who were...
-
Enrollment for Medivation Study - Analyst Blog
Thursday, December 2, 2010 - 1:52pm | 637Medivation, Inc. (MDVN) and partner Astellas Pharma Inc. recently announced that they have finished enrolling patients for a phase III study of their prostate cancer candidate, MDV3100. The phase III study, AFFIRM, is being conducted in men with castration-resistant prostate cancer who were...
-
Benzinga's Top Pre-Market NASDAQ Losers (SQNM, ITRI, SNPS, NFLX)
Thursday, December 2, 2010 - 10:03am | 112Sequenom Inc (NASDAQ: SQNM) dipped 7.05% to $6.33 in the pre-market session. SQNM announced its plans to launch underwritten public offering of its stock. Itron Inc (NASDAQ: ITRI) lost 2.80% to $54.75 in the pre-market session. ITRI's trailing-twelve-month ROE is 6.19%. Synopsys Inc (NASDAQ: SNPS)...
-
Sequenom Announces Public Offering
Wednesday, December 1, 2010 - 5:16pm | 59Sequenom, Inc. (Nasdaq: SQNM) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Jefferies & Company, Inc. is acting as sole book-running manager for the offering and Lazard Capital Markets LLC and Piper Jaffray & Co. are...
-
Sequenom Down 6% On Stock Offering (SQNM)
Wednesday, December 1, 2010 - 5:06pm | 35Sequenom, Inc. (NASDAQ: SQNM) is down more than 6% this evening after the company announced it will be selling stocks. No amount was given in the press release.
-
TMO to Acquire Lomb Scientific - Analyst Blog
Wednesday, December 1, 2010 - 2:10pm | 420Recently, Thermo Fisher Scientific (TMO) decided to acquire Lomb Scientific, which deals in laboratory chemicals, consumables and instruments in Australia and New Zealand. Lomb Scientific, with an employee strength of 100 and revenues of AUD$ 34million, has a wide client base which includes...
-
Zacks #5 Rank Additions for Wednesday - Tale of the Tape
Wednesday, December 1, 2010 - 9:22am | 342Here are 5 stocks added to the Zacks #5 Rank ("strong sell") List today: Accelrys, Inc (ACCL) Banner Corp (BANR) Citi Trends Inc (CTRN) Dresser-Rand Group Inc (DRC) Drew Industries Inc (DW) View the entire Zacks #5 Rank List. ACCELRYS INC (ACCL): Free Stock Analysis Report BANNER CORP (BANR):...
-
TMO to Acquire Lomb Scientific - Analyst Blog
Wednesday, December 1, 2010 - 7:54am | 420Recently, Thermo Fisher Scientific (TMO) decided to acquire Lomb Scientific, which deals in laboratory chemicals, consumables and instruments in Australia and New Zealand. Lomb Scientific, with an employee strength of 100 and revenues of AUD$ 34million, has a wide client base which includes...
-
Zacks #5 Rank Additions for Wednesday - Tale of the Tape
Wednesday, December 1, 2010 - 4:14am | 342Here are 5 stocks added to the Zacks #5 Rank ("strong sell") List today: Accelrys, Inc (ACCL) Banner Corp (BANR) Citi Trends Inc (CTRN) Dresser-Rand Group Inc (DRC) Drew Industries Inc (DW) View the entire Zacks #5 Rank List. ACCELRYS INC (ACCL): Free Stock Analysis Report BANNER CORP (BANR):...
-
Good News for Spectrum Pharma - Analyst Blog
Tuesday, November 30, 2010 - 7:30pm | 482Spectrum Pharmaceuticals (SPPI) recently received encouraging news in the form of the acceptance of its supplemental New Drug Application (sNDA) for cancer candidate Fusilev (levoleucovorin). The application has been considered as a Class II re-submission, implying an early response within 6...
-
AMAG Avoids Black Box Warning - Analyst Blog
Tuesday, November 30, 2010 - 2:30pm | 741AMAG Pharmaceuticals Inc. (AMAG) finally came to an agreement with the US Food and Drug Administration (FDA) regarding an updated label for Feraheme, thus resolving the matter which has been in discussion since the past two months. The shares reacted positively to the news, thereby boosting the...
-
Good News for Spectrum Pharma - Analyst Blog
Tuesday, November 30, 2010 - 1:41pm | 482Spectrum Pharmaceuticals (SPPI) recently received encouraging news in the form of the acceptance of its supplemental New Drug Application (sNDA) for cancer candidate Fusilev (levoleucovorin). The application has been considered as a Class II re-submission, implying an early response within 6...
-
AMAG Avoids Black Box Warning - Analyst Blog
Tuesday, November 30, 2010 - 9:14am | 741AMAG Pharmaceuticals Inc. (AMAG) finally came to an agreement with the US Food and Drug Administration (FDA) regarding an updated label for Feraheme, thus resolving the matter which has been in discussion since the past two months. The shares reacted positively to the news, thereby boosting the...
-
PerkinElmer Completes Divestiture of IDS Business
Monday, November 29, 2010 - 5:47pm | 47PerkinElmer, Inc. (NYSE: PKI) today announced that it has completed the sale of its Illumination and Detection Solutions business to Excelitas Technologies Corp., an affiliate of Veritas Capital Fund Management, L.L.C., a New York-based private equity firm.
-
Market Roundup (LNC, GNW, KEY, TCK, IVN, RIMM, HES, CVX, COP, AMAG, AMRN)
Monday, November 29, 2010 - 1:46pm | 336US Energy stocks fell along with the broader equity market. The top decliners in the list include Hess Corp (NYSE: HES), Chevron Corp (NYSE: CVX) and ConocoPhillips (NYSE: COP). The NYSE Arca Oil Index (XOI) dropped about 0.97%, while the NYSE Arca Natural Gas Index (XNG) moved down about 0.6%....